Neuregulins 1-4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast

Breast Cancer Research and Treatment

Volumn 96, Issue 2, 2006, Pages 163-168

  Marshall, Catherine ^a   Blackburn, Edith ^b   Clark, Mellissa ^b   Humphreys, Steven ^a   Gullick, William J ^b  

^a Preston Hall Hospital   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Breast cancer; Ductal carcinoma; Growth factor; Heregulin; Neuregulin

Indexed keywords

NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR 1 ALPHA; NEU DIFFERENTIATION FACTOR 1 BETA; NEU DIFFERENTIATION FACTOR 2 ALPHA; NEU DIFFERENTIATION FACTOR 2 BETA; NEU DIFFERENTIATION FACTOR 3; NEU DIFFERENTIATION FACTOR 4; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; NEUREGULINS;

EID: 33645235784     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9073-z     Document Type: Article

References (30)

1. Falls DL: Neuregulins: function, forms, and signalling strategies. Exp Cell Res 284: 14-30, 2003
2. Pinkas-Kramarski R, Shelly M, Glathe S, Razkin BJ, Yarden Y: Neu differentiation fator/neuregulin isoforms activate distinct receptor combinations. J Biol Chem 271: 19029-19032, 1996
3. Ben-Baruch N, Yarden Y: Neu differentiation factors: a family of alternatively spliced neuronal and mesenchymal factors. Proc Soc Exp Biol Med 206: 221-227, 1994
4. Higashiyama S, Horikawa M, Yamada K, Ichino N, Nakano N, Nakagawa T, Miyagawa J, Matsushits N, Nagatsu T, Taniguchi N, Ishiguro H: A novel brain-derived member of the Epidermal Growth Factor Family that interacts with ErbB3 and ErbB4. J Biochem 122: 675-680, 1997
5. Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gassman M, Lai C: Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor kinases. Nature 387: 512-516, 1997
6. Chang H, Riese DJ, Gilbert W, Stern DF, McMhan UJ: Ligands for the ErbB-family receptors encoded by a neuregulin-like gene. Nature 387: 509-512, 1997
7. Ring HZ, Chang H, Brice A, LeGuern E, Francke U: The human neuregulin 2 (NRG2) gene: cloning, mapping and evaluation as a candidate for the autosomal recessive form of Charcot-Marie-Tooth disease linked to 5q. Hum Genet 104: 326-332, 1999
8. Yamada K, Ichino N, Nishii K, Sawada H, Higashiyama S, Ishiguro H, Nagatsu T: Characterization of the human NTAK gene structure and distribution of the isoforms for rat NTAK mRNA. Gene 255: 15-24, 2000
9. Crovello CS, Lai C, Cantley LC, Carraway KL: Differential signalling by the Epidermal Growth Factor-like Growth factors Neuregulin-1 and Neuregulin-2. J Biol Chem 273: 26954-26961, 1998
10. Nakano N, Higashiyama S, Kajihara K, Endo T, Ishiguro H, Yamada K, Nagatsu T, Taniguchi N: NTAKα and β isoforms stimulate breast tumour cell growth by means of different receptor combinations. J Biochem 127: 925-930, 2000
11. Hobbs SS, Coffing SL, Le ATD, Cameron EM, Williams EE, Andrew M, Blommel EN, Hammer RP, Chang H, Riese DJ: Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 21: 442-8452, 2002
12. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, Hillan K, Crowley C, Brush J, Godowski PJ: Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 94: 9562-9567, 1997
13. Hijazi MM, Young PE, Dougherty MK, Bressette DS, Cao TT, Pierce JH, Wong LM, Alimandi M, King CR: NRG-3 in human breast cancers: activation of multiple erbB family proteins. Int J Oncol 13: 1061-1067, 1998
14. Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, Yarden Y: Neuregulin-4: a novel growth factor that acts through the ErbB4 receptor tyrosine kinase. Oncogene 18: 2681-2689, 1999
15. Golding M, Ruhrberg C, Sandle J, Gullick WJ: Mapping nucleolar and spliceosome localisation sequences of neuregulin1-beta3. Exp Cell Res 299: 110-118, 2004
16. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC: Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808, 2001
17. Wang S-C, Lien H-C, Xia W, Chen I-F, Lo H-W, Wang Z, Ali-Seyed M, Lee D-F, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC: Binding at and tranactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6: 251-261, 2004
18. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW: c-erbB3: a nuclear protein in mammary epithelial cells. J Cell Biol 157: 929-939, 2002
19. Chang-Yuan N, Murphy MP, Golde TE, Carpenter G: γ-Secretase cleavage and nuclear localisation of ErbB-4 receptor tyrosine kinase. Science 294: 2179-2181, 2001
20. Srinivasan R, Gillett CE, Barnes DM, Gullick WJ: Nuclear expression of the c-erbB-4/HER4 growth factor receptor in invasive breast cancers. Cancer Res 60: 1483-1487, 2000
21. Carpenter G: Nuclear localisation and possible functions of receptor tyrosine kinases. Curr Opin Cell Biol 15: 143-148, 2003
22. Dunn M, Sinha P, Campbell R, Blackburn E, Levinson N, Rampaul R, Bates T, Humphreys S, Gullick WJ: Co-expression of Neuregulin 1, 2, 3 and 4 in human breast cancer. J Path 203: 672-680, 2004
23. Polak JM, Van Noorden S: Introduction to Immunochemistry. (2 ed.). Bios Scientific Publishers, Oxford, 1997
24. Hosmer DW, Lemeshow S: Applied Logistic Regression. (2 ed.). John Wiley and Sons Inc. New York, 2000
25. Bartkova J, Barnes DM, Millis R, Gullick WJ: Immunohistochemical Demonstration of c-erbB-2 protein in mammary Ductal Carcinoma in Situ. Human Pathol 21: 1164-1167, 1990
26. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powles TJ, Price P, McKinna A, Harrison S: Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Int J Can 42: 842-845, 1988
27. Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ: Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 7: 1273-1278, 1992
28. Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Gullick WJ, Hurst HC: Expression of the c-erbB-3 proto-oncogene product in breast cancer. Br J Cancer 66: 1116-1121, 1992
29. Travis A, Bell JA, Wencyk P, Robertson JF, Poller DN, Gullick WJ, Nicholson RI, Blamey RW, Elston CW, Ellis IO: c-erbB-3 in human breast carcinoma - Expression and relation to prognosis and established prognostic indicators. Br J Cancer 74: 229-233, 1996
30. Gullick WJ: The c-erbB-3/HER3 receptor in human cancer. In: Parker PJ and Pawson T (eds) Cancer Surveys. Cold Spring Harbour Laboratory Press, NY, 1996, pp 339-349